• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然化合物在肝脏炎症性疾病中对 Nrf2 和 FXR 的激活作用。

Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease.

机构信息

Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.

Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland.

出版信息

Int J Mol Sci. 2024 Oct 18;25(20):11213. doi: 10.3390/ijms252011213.

DOI:10.3390/ijms252011213
PMID:39456994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11508530/
Abstract

Liver inflammation is frequently linked to oxidative stress and dysregulation of bile acid and fatty acid metabolism. This review focuses on the farnesoid X receptor (FXR), a critical regulator of bile acid homeostasis, and its interaction with the nuclear factor erythroid 2-related factor 2 (Nrf2), a key modulator of cellular defense against oxidative stress. The review explores the interplay between FXR and Nrf2 in liver inflammatory diseases, highlighting the potential therapeutic effects of natural FXR agonists. Specifically, compounds such as auraptene, cafestol, curcumin, fargesone A, hesperidin, lycopene, oleanolic acid, resveratrol, rutin, ursolic acid, and withaferin A are reviewed for their ability to modulate both the FXR and Nrf2 pathways. This article discusses their potential to alleviate liver inflammation, oxidative stress, and damage in diseases such as metabolic-associated fatty liver disease (MAFLD), cholestatic liver injury, and viral hepatitis. In addition, we address the molecular mechanisms driving liver inflammation, including oxidative stress, immune responses, and bile acid accumulation, while also summarizing relevant experimental models. This review emphasizes the promising therapeutic potential of targeting both the Nrf2 and FXR pathways using natural compounds, paving the way for future treatments for liver diseases. Finally, the limitations of the clinical application were indicated, and further research directions were proposed.

摘要

肝脏炎症通常与氧化应激以及胆汁酸和脂肪酸代谢失调有关。本综述重点关注法尼醇 X 受体 (FXR),它是胆汁酸动态平衡的关键调节因子,以及其与核因子红细胞 2 相关因子 2 (Nrf2) 的相互作用,Nrf2 是细胞对抗氧化应激的主要调节因子。本综述探讨了 FXR 和 Nrf2 在肝脏炎症性疾病中的相互作用,强调了天然 FXR 激动剂的潜在治疗效果。具体而言,研究了奥瑞因、咖啡醇、姜黄素、法呢酯 A、橙皮苷、番茄红素、齐墩果酸、白藜芦醇、芦丁、熊果酸和吴茱萸次碱等化合物在调节 FXR 和 Nrf2 通路方面的能力。本文讨论了它们在代谢相关脂肪性肝病 (MAFLD)、胆汁淤积性肝损伤和病毒性肝炎等疾病中缓解肝脏炎症、氧化应激和损伤的潜力。此外,我们还探讨了驱动肝脏炎症的分子机制,包括氧化应激、免疫反应和胆汁酸积累,并总结了相关的实验模型。本综述强调了使用天然化合物靶向 Nrf2 和 FXR 通路的有前途的治疗潜力,为肝脏疾病的未来治疗铺平了道路。最后,指出了临床应用的局限性,并提出了进一步的研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/11508530/89ac01dea158/ijms-25-11213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/11508530/1af3f9cc1a32/ijms-25-11213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/11508530/89ac01dea158/ijms-25-11213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/11508530/1af3f9cc1a32/ijms-25-11213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/11508530/89ac01dea158/ijms-25-11213-g002.jpg

相似文献

1
Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease.天然化合物在肝脏炎症性疾病中对 Nrf2 和 FXR 的激活作用。
Int J Mol Sci. 2024 Oct 18;25(20):11213. doi: 10.3390/ijms252011213.
2
Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.韦德尔内酯通过调节 FXR-胆汁酸-NF-κB/NRF2 轴减轻胆汁淤积性肝损伤,减少胆汁酸积聚及其随后的炎症和氧化应激。
Phytomedicine. 2024 Jan;122:155124. doi: 10.1016/j.phymed.2023.155124. Epub 2023 Sep 29.
3
Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.齐墩果酸通过激活 Fxr 和 Nrf2 通路缓解 ANIT 诱导的胆汁淤积性肝损伤,改善胆汁酸代谢紊乱。
Phytomedicine. 2022 Jul 20;102:154173. doi: 10.1016/j.phymed.2022.154173. Epub 2022 May 14.
4
NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury.NRF2 和 FXR 双重信号通路协同调控齐墩果酸对胆汁淤积性肝损伤的作用。
Phytomedicine. 2023 Jan;108:154529. doi: 10.1016/j.phymed.2022.154529. Epub 2022 Oct 28.
5
Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: a review.天然 Nrf2 信号通路激活剂在胆汁淤积性肝损伤保护中的研究进展:综述。
Eur J Pharmacol. 2021 Nov 5;910:174447. doi: 10.1016/j.ejphar.2021.174447. Epub 2021 Aug 27.
6
Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.姜黄素通过调节肝细胞中的 Nrf2/FXR 信号来减轻乙醇诱导的肝脂肪变性。
IUBMB Life. 2015 Aug;67(8):645-58. doi: 10.1002/iub.1409. Epub 2015 Aug 25.
7
Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.杨芽宁通过体内和体外激活法尼醇 X 受体来防止胆汁淤积和肝毒性。
Toxicol Appl Pharmacol. 2018 Jun 1;348:105-116. doi: 10.1016/j.taap.2018.04.015. Epub 2018 Apr 14.
8
Patented Farnesoid X receptor modulators: a review (2019 - present).专利法尼醇 X 受体调节剂:综述(2019 年至今)。
Expert Opin Ther Pat. 2024 Jul;34(7):547-564. doi: 10.1080/13543776.2024.2314296. Epub 2024 Feb 26.
9
Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice.奥贝胆酸通过激活 db/db 小鼠的 FXR/Nrf2 信号通路来预防糖尿病心肌病。
Eur J Pharmacol. 2019 Sep 5;858:172393. doi: 10.1016/j.ejphar.2019.05.022. Epub 2019 May 11.
10
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis.法尼醇 X 受体激动剂奥贝胆酸对 Mafg 和 Nrf2 的相反作用介导了胆汁淤积性肝损伤模型啮齿动物的急性肝损伤的发生。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158733. doi: 10.1016/j.bbalip.2020.158733. Epub 2020 May 1.

引用本文的文献

1
Attenuation of chlorpyrifos-induced liver injury, oxidative stress and inflammation by selenium nanoparticles via SIRT1/FXR/Nrf2 signaling pathway modulation.硒纳米颗粒通过SIRT1/FXR/Nrf2信号通路调节减轻毒死蜱诱导的肝损伤、氧化应激和炎症
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 23. doi: 10.1007/s00210-025-04465-5.
2
Liver disorders and phytotherapy.肝脏疾病与植物疗法。
Toxicol Rep. 2025 May 10;14:102047. doi: 10.1016/j.toxrep.2025.102047. eCollection 2025 Jun.
3
Identification of Food-Derived Electrophilic Chalcones as Nrf2 Activators Using Comprehensive Virtual Screening Techniques.

本文引用的文献

1
Biomarkers of Hepatic Toxicity: An Overview.肝毒性生物标志物:概述
Curr Ther Res Clin Exp. 2024 Apr 26;100:100737. doi: 10.1016/j.curtheres.2024.100737. eCollection 2024.
2
The ameliorative effect of turmeric (Curcuma longa Linn) extract and its major constituent, curcumin, and its analogs on ethanol toxicity.姜黄(Curcuma longa Linn)提取物及其主要成分姜黄素及其类似物对乙醇毒性的改善作用。
Phytother Res. 2024 May;38(5):2165-2181. doi: 10.1002/ptr.8165. Epub 2024 Feb 23.
3
Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway.
运用综合虚拟筛选技术鉴定食品来源的亲电查尔酮作为Nrf2激活剂
Antioxidants (Basel). 2025 Apr 30;14(5):546. doi: 10.3390/antiox14050546.
4
Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease.揭示肠-肝轴:微生物在代谢相关脂肪性肝病发病机制中的作用
Front Microbiol. 2025 Apr 25;16:1577724. doi: 10.3389/fmicb.2025.1577724. eCollection 2025.
5
Curcumin: A Natural Warrior Against Inflammatory Liver Diseases.姜黄素:对抗炎症性肝病的天然斗士。
Nutrients. 2025 Apr 18;17(8):1373. doi: 10.3390/nu17081373.
芦丁通过AMPK/SREBP1通路改善糖尿病性非酒精性脂肪性肝病的脂质代谢功能障碍。
Phytomedicine. 2024 Apr;126:155437. doi: 10.1016/j.phymed.2024.155437. Epub 2024 Feb 9.
4
Therapeutic potential of oleanolic acid in liver diseases.齐墩果酸在肝脏疾病中的治疗潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4537-4554. doi: 10.1007/s00210-024-02959-2. Epub 2024 Jan 31.
5
Research progress on rodent models and its mechanisms of liver injury.啮齿动物肝损伤模型及其机制的研究进展
Life Sci. 2024 Jan 15;337:122343. doi: 10.1016/j.lfs.2023.122343. Epub 2023 Dec 15.
6
Overview of Ursolic Acid Potential for the Treatment of Metabolic Disorders, Autoimmune Diseases, and Cancers via Nuclear Receptor Pathways.熊果酸通过核受体途径治疗代谢紊乱、自身免疫性疾病和癌症的潜力概述。
Biomedicines. 2023 Oct 19;11(10):2845. doi: 10.3390/biomedicines11102845.
7
The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis.组织特异性法尼醇 X 受体对胆汁酸动态平衡相关基因和疾病的调控。
Biomed Pharmacother. 2023 Dec;168:115606. doi: 10.1016/j.biopha.2023.115606. Epub 2023 Oct 7.
8
Ursolic acid attenuates cholestasis through NRF2-mediated regulation of UGT2B7 and BSEP/MRP2.熊果酸通过 NRF2 介导的 UGT2B7 和 BSEP/MRP2 调节减轻胆汁淤积。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2257-2267. doi: 10.1007/s00210-023-02733-w. Epub 2023 Oct 9.
9
Unfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review.肝疾病中未折叠蛋白反应信号通路:2023 年更新综述
Int J Mol Sci. 2023 Sep 14;24(18):14066. doi: 10.3390/ijms241814066.
10
Advances in Understanding the Role of NRF2 in Liver Pathophysiology and Its Relationship with Hepatic-Specific Cyclooxygenase-2 Expression.NRF2在肝脏病理生理学中的作用及其与肝脏特异性环氧化酶-2表达关系的研究进展
Antioxidants (Basel). 2023 Jul 26;12(8):1491. doi: 10.3390/antiox12081491.